Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07316777

Saudi CABG Audit and Registry

Protocol for Development and Implementation of the Saudi CABG Audit and Registry: A Prospective National Clinical Registry

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
King Faisal Specialist Hospital & Research Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Saudi CABG Audit and Registry (SCAR) is a prospective, multicenter national clinical quality registry designed to systematically collect perioperative and long-term outcome data for all patients undergoing coronary artery bypass grafting (CABG) in Saudi Arabia. The registry will begin with a pilot phase in selected tertiary cardiac centers and will progressively expand to national coverage. SCAR captures detailed information on patient demographics, cardiac status, operative techniques, postoperative outcomes, and 1-year follow-up, including patient-reported quality-of-life measures (EQ-5D and SF-36). The aim is to establish a standardized national platform for benchmarking, quality improvement, and real-world evidence generation to support clinical decision-making and health policy development in cardiac surgery. Data are collected prospectively through secure electronic systems, anonymized before central storage, and analyzed using standardized definitions aligned with international registries such as STS and E-CABG.

Conditions

Interventions

TypeNameDescription
OTHERProspective Clinical Data CollectionThe intervention consists of systematic, prospective collection of standardized clinical, operative, and follow-up data for all adult patients undergoing coronary artery bypass grafting (CABG) at participating centers. Data are recorded across predefined time points, including preoperative assessment, intraoperative details, postoperative in-hospital outcomes, and follow-up at 30 days, 3 months, 6 months, and 1 year. Variables include demographics, comorbidities, cardiac status, operative technique, complications, readmissions, mortality, and patient-reported quality-of-life measures (EQ-5D and SF-36). No treatments are assigned. The registry functions solely as an observational platform for quality improvement, benchmarking, and long-term outcome monitoring.

Timeline

Start date
2026-01-01
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2026-01-05
Last updated
2026-01-05

Source: ClinicalTrials.gov record NCT07316777. Inclusion in this directory is not an endorsement.